Corporate Strategy

We strive to identify and acquire pharmaceutical products that address key unmet medical needs or expand patient treatment options — particularly therapies which are in late-stage development or are already on the market but have not yet realized their commercial potential.

Marathon is committed to growth through its business development initiatives. Starting from acquisition, our growth strategy is designed to provide significant value enhancement.

THE MARATHON WAY

Acquire, develop, commercialize, and enhance lives — that’s the Marathon way.

Marathon brings intense focus and analysis to every new product. Once committed to an acquisition or partnership, we utilize our years of experience in building brand equity to promote active brand management and a periodic re-evaluation of the product’s marketing fundamentals.

We have a track record of turning niche opportunities, often unrecognized or undeveloped by others, into case-study successes in the marketplace, with ultimate benefit to the patients who live fuller lives.

LIFECYCLE MANAGEMENT

Marathon views every product initiative in the same way, as a lifecycle commitment with long-term planning for improvement and revenue growth during each of the major product life segments:

• Build platform for growth during clinical development
• Accelerate speed to value for product launch
• Maximize product commercialization

Learn about our MANAGEMENT >>

Product Acquisitions

Are you selling a product that is in late-stage approval or already on the market? Learn more >>

Strategic Partnerships

Marathon places high value on collaboration. See if we are right for each other >>